Cytokine response after percutaneous coronary intervention in stable angina: Effect of selective glycoprotein IIb/IIIa receptor antagonism

American Heart Journal

Volumn 145, Issue 4, 2003, Pages 693-699

  Bonz, Andreas W ^a,b   Lengenfelder, Björn ^a   Jacobs, Martina ^a   Strotmann, Jörg ^a   Held, Stefanie ^a   Ertl, Georg ^a   Voelker, Wolfram ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; FIBRINOGEN RECEPTOR ANTAGONIST; INTERLEUKIN 1; INTERLEUKIN 6; PLACEBO; TIROFIBAN; TROPONIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; DRUG INFUSION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MYOCARDITIS; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; STABLE ANGINA PECTORIS;

EID: 0037386149     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2003.65     Document Type: Article

References (34)

1. Yarnell JWG, Baker IA, Sweetnam A, et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. Circulation 1991;88;836-44.
2. Van der Wal AC, Becker AE, van der Loos CM, et al. Site of intimal rupture or erosion of thrombosed coronary arterosclerotic plaque is characterized by an inflammation process irrespective of the dominant plaque morphology. Circulation 1994;90:36-44.
3. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999;340:115-26.
4. Ikonomides I, Andreotti F, Economou E, et al. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation 1999;100:793-8.
5. Biasucci LM, Vitelli A, Liuzzo G, et al. Elevated levels of interleukin-6 in unstable angina. Circulation 101:302-9.
6. Liuzzo G, Buffon A, Biasuci L, et al. Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina Circulation 1996;94:874-7.
7. Gaspardone A, Crea F, Versaci F, et al. Predictic value of C-reactive protein after successful coronary artery stenting in patients with stable angina. Am J Cardiol 1998;82:515-8.
8. Versaci F, Gaspardone A, Tomai F. Predictic value of C-reactive protein in patients with unstable angina undergoing coronary stent implantation. Am J Cardiol 2000;85:92-5.
9. Lincoff AM, Kereiakes DJ, Mascelli MA, et al. Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularisation. Circulation 2001;104:163-7.
10. Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined. Eur Heart J 2000;21:1502-13.
11. King SB for the RESTORE Investigators. Effect of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Circulation 1997;96:1445-53.
12. Cannon PC for the TACTICS-Thrombolysis In Myocardial Infarction 18 Investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes trated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001;344:1879-87.
13. 3 integrin-mediated binding of smooth muscle cells to thrombospodin and prothrombin. Circulation 2001;104:582-7.
14. Hanson GK, Jonason L, Seifert PS, et al. Immune mechanism in atherosclerosis. Atherosclerosis 1989;9:567-78.
15. Bataille R, Klein B. C-reactive protein levels as a direct indicator of interleukin 6 levels in humans in vivo. Arthritis Rheum 1992;35:982-4.
16. Nawroth PP, Stern DM. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 1986;163:740-5.
17. Herkowitz A, Choi S, Ansari AA, et al. Cytokine mRNA expression in post-ischemic/reperfused myocardium. Am J Pathol 1995;146:419-28.
18. Seino Y, Ikeda U, Yamamoto K, et al. Interleukin-6 gene transcripts are expressed in human atherosclerotic lesions. Cytokine 1994;6:87-91.
19. Serrano CV, Ramires JAF, Venturinelli M, at al. Coronary angiolasty results in leucocyte and platelet activation with adhesion molecule expession. J Am Coll Cardiol 1997;29:1276-83.
20. Blum A, Sclarovsky S, Shohat B. T lymphocytes activation in stable angina pectoris and after percutaneous transluminal coronary angioplasty. Circulation 1995;91:20-2.
21. Akira S, Hirano T, Taga T, et al. Biology of multifunctional cytokines: IL 6 and related molecules (IL-1 and TNF-α). FASEB J 1990;4:2860-7.
22. Hojo Y, Ikeda U, Katsuki T, et al. Interleukin 6 expresion in coronary circulation after coronary angioplosty as a risk factor for restenosis. Heart 2000;84:83-7.
23. Gottsauner-Wolf M, Zasmeta G, Hornykewycz M, et al. Plasma levels of C-reactive protein after coronary stent implantation. Eur Heart J 2000;21:1152-8.
24. Ridker PM, Rifai N, Stampfer MJ, et al. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000;101:1767-72.
25. Tam SH, Sassoli PM, Jordan RE, et al. Abciximab (ReoPro, chimeric 7E3 Fab) demonstrates equivalent affinity and functional blockade of glycoprotein IIb/IIIa and avβ3 integrins. Circulation 1998;98:1085-91.
26. Simon DI, Xu H, Ortlepp S, et al. 7E3 monoclonal antibody directed against the platelet glycoprotein IIb/IIIa cross reacts with the leucocyte integrin MAC-1 and blocks adhesion to fibrinogen and ICAM-1. Thromb Vasc Biol 1997;17:528-35.
27. Neumann FJ, Ott I, Gawatz M, et al. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulotion 1995;92:748-55.
28. Gurevitch J, Frolkis I, Yuhas Y, et al. Anti-tumor necrosis factor alpha improves myocardial recovery after ischemia and reperfusion. J Am Coll Cardiol 1997;30:1554-61.
29. Li D, Zhao L, Liu M, et al. Kinetics of tumor necrosis factor alpha in plasma and the cardioprotective effect of a monoclonal antibody to tumor necrosis factor alpha in acute myocardial infarction. Am Heart J 1999;137:1145-52.
30. Kato K, Matsubara T, Iida K, et al. Elevated levels of proinflammatory cytokines in coronary artery thrombi. Int J Cardiol 1999;70:267-73.
31. Topol EJ for the EPISTENT-Investigators. Randomized placebo-controlled and ballon-angioplasty-controlled trial to assess safety of coronary stenting with use of glycoprotein IIb/IIIa blockade. Lancet 1998;352:87-92.
32. Arras M, Strasser R, Mohri M, et al. Tumor necrosis factor alpha is expressed by monocytes/macrophages following cardiac microembolisation and is antagonized by cyclosporine. Basic Res Cardiol 1998;93:97-107.
33. Schindler R, Mancilla J, Endres S, et al. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 1990;75:40-7.
34. Nossuli TO, Lakshminarayanan V, Baumgarten G, et al. A chronic mouse model of ischemia-reperfusion: esential for cytokine studies. Am J Physiol Heart Circ Physiol 2000;278:H1049-55.